Comparison of 18F-FDG PET/CT and 18F-FAPI PET/CT in Systemic Staging of Newly Diagnosed Breast Cancer

被引:0
|
作者
Ji, Bin [1 ]
Li, Wenjia [2 ]
Wang, Wan [2 ]
Min, Kaiyin [1 ]
Yang, Bowen [1 ]
Wan, Qichang [3 ]
Liu, Junzhi [1 ]
Gao, Shi [1 ]
机构
[1] Jilin Univ, Dept Nucl Med, China Japan Union Hosp, Changchun 130033, Peoples R China
[2] Jilin Univ, Dept Breast Surg, China Japan Union Hosp, Changchun 130033, Peoples R China
[3] Guangzhou Med Univ, Affiliated Qingyuan Hosp, Qingyuan Peoples Hosp, Dept Nucl Med, Qingyuan 511500, Peoples R China
关键词
F-18-FAPI PET/CT; F-18-FDG PET/CT; Breast cancer; Systemic staging; Sensitivity;
D O I
10.1016/j.acra.2024.07.058
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives: The purpose of this study was to compare the performance of F-18-FAPI PET/CT and F-18-FDG PET/CT in systemic staging of newly diagnosed breast cancer. Methods: Breast cancer patients with initial clinical stage IIB-IIIC who have consequently underwent both F-18-FAPI and F-18-FDG PET/CT from June 2022 to June 2023 were retrospectively analyzed. New clinical stage was assigned to each patient if unsuspected level III axillary and extraaxillary regional lymph node metastases (URNM) and/or distant metastases were disclosed after PET/CT. Sensitivity for both tests was calculated on patient basis and lesion basis using histology or follow-up imaging as reference standard. Results: 38 patients were included. The overall upstaging rate was 47.4% for F-18-FAPI PET/CT (18/38) and 34.2% for F-18-FDG PET/CT (13/38). The rate of distant metastases disclosed by F-18-FAPI PET/CT was 5.5% in stage IIB patients, 30% in stage IIIA patients, 50% in stage IIIB patients, and 75% in stage IIIC patients. On patent-based analysis, the sensitivity of F-18-FAPI PET/CT was significantly different from that of F-18-FDG PET/CT in detecting URNM [100% (13/13) vs 53.8% (7/13), (P = 0.031)], but not for distant metastases [100% (10/10) vs 90% (9/10), (P = 1.000)]. On lesion-based analysis, the sensitivity of F-18-FAPI PET/CT was significantly higher than that of F-18-FDG PET/CT in detecting URNM [97.6% (41/42) vs 52.4% (22/42), (P < 0.001)] and distant metastases [98.1% (51/52) vs 67.3% (35/52), (P < 0.001)]. Conclusion: F-18-FAPI PET/CT leads to significant upstaging in newly diagnosed breast cancer, in a rate higher than F-18-FDG PET/CT. The significantly higher lesion-based sensitivity in unsuspected metastases implies a future role of F-18-FAPI PET/CT in evaluation of metastatic disease burden. (c) 2024 The Association of University Radiologists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 50 条
  • [1] FAPI VersusA 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer
    Hao, Zhixin
    Pan, Bo
    Yao, Ru
    Zhou, Yidong
    Sun, Qiang
    Huo, Li
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [2] 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men
    Ulaner, Gary A.
    Juarez, Jessica
    Riedl, Christopher C.
    Goldman, Debra A.
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (04) : 472 - 477
  • [3] Comparison of 18F-FAPI and 18F-FDG PET/CT in a Patient With Fibrous Dysplasia
    Mu, Xingyu
    Li, Zuguo
    Qin, Jie
    Wang, Zhenzhen
    Fu, Wei
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (04) : e182 - e183
  • [4] 18F-FDG PET/CT Versus 18F-FAPI PET/CT in a Case of Recurrent Malignant Phyllodes Breast Tumor
    Jiang, Shuqin
    Jiang, Ming
    Rao, Songquan
    Liang, Jiucen
    Zhang, Rusen
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : E35 - E37
  • [5] Staging of Breast Cancer with 18F-FDG PET and PET/CT
    Aukema, Tjeerd S.
    Rutgers, Emiel J. T.
    Vogel, Wouter V.
    Olmos, Renato A. Valdes
    CURRENT MEDICAL IMAGING REVIEWS, 2009, 5 (04) : 203 - 209
  • [6] 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Triple Negative Breast Cancer (TNBC)
    Castillo, Raychel
    Goldman, Debra
    Ulaner, Gary
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [7] 18F-FAPI versus 18F-FDG PET/CT in the Diagnosis of Relapsing Polychondritis
    Guo, Xiaotong
    Chen, Juan
    Zhao, Qian
    Liu, Ying
    Wang, Xiuyan
    CLINICAL CASE REPORTS, 2024, 12 (12):
  • [8] Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma
    Jing Zhang
    Shuqin Jiang
    Mengsi Li
    Haibao Xue
    Xi Zhong
    Shuyi Li
    Hao Peng
    Jiuceng Liang
    Zhidong Liu
    Songquan Rao
    Haipeng Chen
    Zewen Cao
    Yuanfeng Gong
    Guoshuo Chen
    Rusen Zhang
    Linqi Zhang
    Cancer Imaging, 23
  • [9] Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma
    Zhang, Jing
    Jiang, Shuqin
    Li, Mengsi
    Xue, Haibao
    Zhong, Xi
    Li, Shuyi
    Peng, Hao
    Liang, Jiuceng
    Liu, Zhidong
    Rao, Songquan
    Chen, Haipeng
    Cao, Zewen
    Gong, Yuanfeng
    Chen, Guoshuo
    Zhang, Rusen
    Zhang, Linqi
    CANCER IMAGING, 2023, 23 (01)
  • [10] 18F-FAPI PET/CT performs better in evaluating mediastinal and hilar lymph nodes in patients with lung cancer: comparison with 18F-FDG PET/CT
    Sun, Yuyun
    Sun, Yun
    Li, Zili
    Song, Shaoli
    Wu, Kailiang
    Mao, Jingfang
    Cheng, Jingyi
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01)